The Swedish authority is initating an inspection of research projects of five pharmaceutical companies.
The Data Inspection Board will among other things investigate how the companies inform participants about how their personal information will be handled and getting their approval to register this type of information. The five pharmaceutical companies are according to Läkemedelsvärlden and Life Science Sweden Novartis, Roche, MSD, Pfizer and Bristol Myers Squibb.
“As we have previously looked over research projects of universities, university colleges and authorities inadequacies have been identified. Now, we want to investigate the situation in the private sector,” said Victoria Söderqvist at the Data Inspection Board in a press release. Söderqvist is conducting the investigation.
The inspection will be carried out in two phases. The Data Inspection Board will firstly do an inventory of what research projects the five companies are running. Then, a number of research projects from each company will be selected for further inspection.